FDA clears advanced smartwatch capable of detecting AFib
Anthony Vecchione | October 18, 2021 | Cardiovascular Business | Heart Rhythm
Withings watch

Withings, an international healthcare technology company, has received FDA clearance for ScanWatch, its wearable solution that can track a person's heart rate, identify signs of atrial fibrillation (AFib) and more. 

ScanWatch will be available in North America in November. It was launched in Europe in 2020. 

"ScanWatch has been clinically validated to detect AFib and can aid in the detection of breathing disturbances at night, that can be signs of sleep apnea. " Mathieu Letombe, CEO of Withings, said in a press release. "It is our most ambitious medical watch to date and has the potential to benefit millions of people."

The company said that ScanWatch can identify signs of AFib due to its ability to take a medical-grade ECGs. The solution was also designed to notify a patient of potential heart events.

ScanWatch can also be used to monitor blood oxygen levels and to detect if a patient is having difficulty breathing, the company added. 

Anthony Vecchione

Related Content

American Heart Association thinks pharmacists can play a bigger role in AFib care
2 out of 5 AFib patients develop heart failure later in life
FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
Biosense Webster takes key step toward FDA approval for Varipulse PFA system
Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup